Learn more

ESPERION THERAPEUTICS INC

Overview
  • Total Patents
    314
  • GoodIP Patent Rank
    17,974
  • Filing trend
    ⇧ 100.0%
About

ESPERION THERAPEUTICS INC has a total of 314 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 1992. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ANTIBE THERAPEUTICS INC, ANDROSCIENCE CORP and PROMENTIS PHARMACEUTICALS INC.

Patent filings per year

Chart showing ESPERION THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Oniciu Carmen Daniela 72
#2 Dasseux Jean-Louis H 51
#3 Bisgaier Charles L 48
#4 Dasseux Jean-Louis Henri 38
#5 Lalwani Narendra D 34
#6 Dasseux Jean-Louis 26
#7 Rodrigueza Wendi V 22
#8 Johansson Jan 22
#9 Hartman Daniel 22
#10 Rosenberg Noah Laban 21

Latest patents

Publication Filing date Title
WO2020257571A1 Methods of making bempedoic acid and compositions of the same
WO2020046836A1 Combination drug formulations for treating patients with cardiovascular disease and associated conditions
CA3110346A1 Methods for reducing the risk of diabetes in patients being treated for high cholesterol-related illnesses
WO2019161307A1 Sustained release formulations of bempedoic acid
CN110536684A Three combination preparations and treatment cardiovascular disease or the method for reducing risk of cardiovascular diseases
US2018338922A1 Fixed dose formulations
BR112017019728A2 fixed dose combinations and formulations comprising etc1002 and one or more statins and method for treating or reducing the risk of cardiovascular disease
UA123355C2 Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
AU2015231076A1 Carboxy-cyclopropyl undecanol compounds for treatment of liver disease and other medical disorders
US2015150939A1 Apolipoprotein mixtures
WO2011143362A1 Dimeric oxidation-resistant apolipoprotein a1 variants
AU2007201462A1 Ketone compounds and compositions for cholesterol management and related uses
AU2005201466A1 Ether compounds, compositions, and uses thereof
BRPI0415514A pharmaceutical formulations, methods and dosage regimens for the treatment and prevention of acute coronary syndromes
CN1870894A Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes
AU2003300438A1 Ether compounds and compositions for cholesterol management and related uses
AU2003304703A1 Ketone compounds and compositions for cholesterol management and related uses
US2007149615A9 Ketone compounds and compositions for cholesterol management and related uses
WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
AU2003300177A1 Urea and thiourea compounds and compositions for cholesterol management and related uses